Free Trial
NASDAQ:ADUS

Addus HomeCare (ADUS) Stock Price, News & Analysis

Addus HomeCare logo
$110.19 +1.09 (+1.00%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$110.19 0.00 (0.00%)
As of 08/8/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Addus HomeCare Stock (NASDAQ:ADUS)

Key Stats

Today's Range
$107.71
$110.21
50-Day Range
$104.96
$118.00
52-Week Range
$88.96
$136.72
Volume
143,903 shs
Average Volume
180,157 shs
Market Capitalization
$2.03 billion
P/E Ratio
24.32
Dividend Yield
N/A
Price Target
$142.86
Consensus Rating
Buy

Company Overview

Addus HomeCare Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
98th Percentile Overall Score

ADUS MarketRank™: 

Addus HomeCare scored higher than 98% of companies evaluated by MarketBeat, and ranked 27th out of 923 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Addus HomeCare has received a consensus rating of Buy. The company's average rating score is 3.25, and is based on 6 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Addus HomeCare has only been the subject of 3 research reports in the past 90 days.

  • Read more about Addus HomeCare's stock forecast and price target.
  • Earnings Growth

    Earnings for Addus HomeCare are expected to grow by 16.78% in the coming year, from $4.59 to $5.36 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Addus HomeCare is 24.32, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 27.88.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Addus HomeCare is 24.32, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 29.76.

  • Price to Earnings Growth Ratio

    Addus HomeCare has a PEG Ratio of 1.64. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Addus HomeCare has a P/B Ratio of 1.99. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    3.68% of the outstanding shares of Addus HomeCare have been sold short.
  • Short Interest Ratio / Days to Cover

    Addus HomeCare has a short interest ratio ("days to cover") of 4.3.
  • Change versus previous month

    Short interest in Addus HomeCare has recently decreased by 2.84%, indicating that investor sentiment is improving.
  • Dividend Yield

    Addus HomeCare does not currently pay a dividend.

  • Dividend Growth

    Addus HomeCare does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.68% of the outstanding shares of Addus HomeCare have been sold short.
  • Short Interest Ratio / Days to Cover

    Addus HomeCare has a short interest ratio ("days to cover") of 4.3.
  • Change versus previous month

    Short interest in Addus HomeCare has recently decreased by 2.84%, indicating that investor sentiment is improving.
  • News Sentiment

    Addus HomeCare has a news sentiment score of 0.91. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.38 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 21 news articles for Addus HomeCare this week, compared to 6 articles on an average week.
  • Search Interest

    2 people have searched for ADUS on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Addus HomeCare to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Addus HomeCare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $235,175.00 in company stock.

  • Percentage Held by Insiders

    Only 4.60% of the stock of Addus HomeCare is held by insiders.

  • Percentage Held by Institutions

    95.35% of the stock of Addus HomeCare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Addus HomeCare's insider trading history.
Receive ADUS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Addus HomeCare and its competitors with MarketBeat's FREE daily newsletter.

ADUS Stock News Headlines

Why AMZN, GOOG, MSFT might destroy NVDA
Investing Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.
Addus HomeCare (NASDAQ:ADUS) Price Target Raised to $139.00
See More Headlines

ADUS Stock Analysis - Frequently Asked Questions

Addus HomeCare's stock was trading at $125.35 on January 1st, 2025. Since then, ADUS stock has decreased by 12.1% and is now trading at $110.19.

Addus HomeCare Corporation (NASDAQ:ADUS) posted its quarterly earnings data on Monday, August, 4th. The company reported $1.49 earnings per share for the quarter, topping analysts' consensus estimates of $1.45 by $0.04. Addus HomeCare's quarterly revenue was up 21.8% on a year-over-year basis.
Read the conference call transcript
.

Addus HomeCare's top institutional investors include WCM Investment Management LLC (2.66%), Geode Capital Management LLC (2.48%), TimesSquare Capital Management LLC (2.14%) and Boston Partners (1.14%). Insiders that own company stock include R Dirk Allison, W Bradley Bickham, Darby Anderson, Brian Poff, Sean Gaffney, Monica Raines, Cliff Donald Blessing, Roberton James Stevenson, Michael D Wattenbarger, David W Tucker and Esteban Lopez.
View institutional ownership trends
.

Shares of ADUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Addus HomeCare investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Adobe (ADBE), Eli Lilly and Company (LLY) and ServiceNow (NOW).

Company Calendar

Last Earnings
8/04/2025
Today
8/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - OUTP/HM CRE
Sub-Industry
Healthcare
Current Symbol
NASDAQ:ADUS
CIK
1468328
Employees
49,703
Year Founded
N/A

Price Target and Rating

High Price Target
$150.00
Low Price Target
$133.00
Potential Upside/Downside
+29.6%
Consensus Rating
Buy
Rating Score (0-4)
3.25
Research Coverage
8 Analysts

Profitability

EPS (Trailing Twelve Months)
$4.53
Trailing P/E Ratio
24.32
Forward P/E Ratio
24.01
P/E Growth
1.64
Net Income
$73.60 million
Net Margins
6.51%
Pretax Margin
8.67%
Return on Equity
9.39%
Return on Assets
6.86%

Debt

Debt-to-Equity Ratio
0.17
Current Ratio
1.74
Quick Ratio
1.74

Sales & Book Value

Annual Sales
$1.15 billion
Price / Sales
1.76
Cash Flow
$5.44 per share
Price / Cash Flow
20.24
Book Value
$55.51 per share
Price / Book
1.99

Miscellaneous

Outstanding Shares
18,410,000
Free Float
17,560,000
Market Cap
$2.03 billion
Optionable
Optionable
Beta
0.80

Social Links

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:ADUS) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners